Pricing Log in Create free account
Saturday 17 October 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

86.06 1.65 −1.88%
Market cap
$33.1B
P/E
33.2×
Fwd P/E
29.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

DexCom, Inc. (DXCM) Net margin

Alert me on Net margin

DexCom, Inc.'s net margin over the twelve months to 30 June 2026 was 20.1%, up 2.2 percentage points from fiscal 2025 (17.9%). Over the past ten years it has ranged from −14.3% (fiscal 2015) to 28.5% (fiscal 2020); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −20.4% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 17.9% 3.65
FY2024 14.3% (0.66)
FY2023 15.0% 3.22
FY2022 11.7% 2.87
FY2021 8.86% (19.67)
FY2020 28.5% 21.68
FY2019 6.85% 19.17
FY2018 −12.3% (5.33)
FY2017 −6.99% 4.45
FY2016 −11.4% 2.89

Quarterly newest first

Period Net margin Change (points)
Jun 2026 19.0% 2.30
Mar 2026 16.7% (4.48)
Dec 2025 21.2% (2.25)
Sep 2025 23.5% 7.93
42 more quarters

Against its own ten years

Low −14.3% High 28.5%
Ten-year median 8.86%
Current reading's percentile 90

Net margin against peers

Company Net margin
DXCM DexCom, Inc. 20.1%
BSX Boston Scientific Corporation compare 17.5%
EW Edwards Lifesciences Corporation compare 15.4%
STE STERIS plc compare 13.3%
PEN Penumbra, Inc. compare 10.7%
ZBH Zimmer Biomet Holdings, Inc. compare 9.48%
GEHC GE HealthCare Technologies Inc. compare 9.33%
SNN Smith & Nephew SNATS, Inc. compare 6.71%
PHG Koninklijke Philips N.V. compare 6.24%
Medical Devices industry median −20.4%
Healthcare sector median 0.00%
Market median 0.45%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on DXCM